Акционерное общество с ограниченной ответственностью «Фармацевтическая корпорация Боай Синькайюань» (BOAI NKY MEDICAL HOLDINGS LTD.). Сокращенное наименование: Синькайюань (NKY), биржевой тикер: 300109. Основная сфера деятельности компании: производство серий продуктов на основе поливинилпирролидона (PVP), сополимеров метилвинилового эфира и малеинового ангидрида (PVM/MA, OraRez®), а также средств ухода за полостью рта; услуги по проведению скринингов с целью раннего выявления новообразований на основании секвенирования генома в качестве основной методики, услуги молекулярной диагностики, персонализированной медицины и другие услуги медицинского и фармацевтического характера. В настоящее время к дочерним компаниям NKY относятся: ООО «Фармацевтическая компания Боай Синькайюань (Пекин)»; ООО «Международная торговая компания Тяньцзинь Боай Синькайюань»; ООО «Фармацевтическая компания Тяньцзинь Яжуйцзы»; ООО «Боай Синькайюань по производству оборудования для химической и фармацевтической промышленности»; ООО «Фармацевтическая компания Wuhan HEER»; ООО «Биотехнологическая компания ЗG», г. Чаньша; ООО «Биотехнологическая компания Цзиннэн (Шанхай)». Дочерняя компания за рубежом: ООО «Химическая промышленная компания Боай Синькайюань», Германия. Совместное предприятие за рубежом: Фармацевтическая акционерная компания «Синькайюань», Япония.
Вспомогательные вещества, используемые при изготовлении лекарственных препаратов: поливинилпирролидон (PVP), кросповидон (PVPP), коповидон (VP/VA), повидон-йод (PV)
PVP: обработка воды, термоклей, полиграфия, набивка и крашение, текстиль, нефтедобыча, стекловолокно
OraRez® MS Стабилизатор зубных протезов
OraRez® W Растворяет активные вещества в зубной пасте и жидкости для полоскания рта, образует пленку на поверхности зубов и полости рта
PolyViscol® серия K, серия VA: пленкообразователь, загуститель средств для укладки волос; стабилизатор для кремов, эмульсий
Сохранение первоначальной формы, восстановление: стабилизатор пива, вина, чая и других напитков, удаление полифенолов.
Мономер NVP (винилпирролидон), 2-P (2-пирролидон), виниловые эфиры
From 5th to 7th of April, 2022, BOAI NKY PHARMACEUTICALS LTD., a subsidiary company of Boai NKY Medical Holdings Ltd. (Stock Code: 300109), took part in the “in-cosmetics®Global” global personal cosmetics raw materials exhibition with a few new products. In this event, NKY released three new co-polymer products: PoliRez®, Nokesho® and DermaRez®, in which DermaRez® is a raw material product NKY has developed for skin care application. These new products launched this time enrich the variety of NKY products and provide customers of NKY with more options. Get to know NKY State-of-the-art production facilityGlobal supply with local (safety) stockDedicated customer service & supportStrong quality management systemFocused environmental awarenessPartnered product developmentTransparent communicationContinuous investmentCustomer base representing SMEs to MNCs The right choice for new product development and sourcing of your PVP and PVM/MA commercial products.
Read more<<The political and business delegation from California state which participated in Henan International Investment Fair, made a visit to Boai NKY under the leadership of Mayor Pro Tem Samuel Kang (City of Duarte, CA) in the afternoon of April 6th, 2019.Group photo of guests All guests were given a warmly reception in Boai NKY by our Vice president-Mr. Wong Jiangqiang. Mr. Wong made a brief introduction on the development history of Boai NKY, and a detailed description of business progress in markets of functional polymer materials & precise medical service. As an international operation company, by acquisition of a biogical company-Bio Vision (completed on March, 2018), and in-depth cooperation with Illumina, a leading company in high-throughput genome sequencing technology, Boai NKY has created extensive business relationship with California state, which brings us a promising prospect to technology application in aspects of medical research & clinical diagnosis. 25% special tariff is placed on polymer materials that Boai NKY exporting to US market (Two kinds of polymer materials were categorized as special tariff products in List 2). Taking this unfair treatment as example, Mr. Wong stressed his belief that China and the US both stand to gain from cooperation and lose from confrontation. Mr. Wong do hope that all delegates could pay full attention to the tariff issue, and play respective influence on trade negotiation between China & US for a win-win result by withdrawing special tariff on both sides. Mayor Pro Tem Samuel Kang, together with Mayor Mr. Rey Leon and Supervisor Mr. Rodrigo Espinoza (Merced County, CA) gave positive responses to Mr. Wong's belief. They all hope that the trade war between China & US could be peacefully ended as soon as possible, which is also the main purpose of the visit of delegation. They completely agree with us that China & US should be friends instead of enemies.Vice chairman wang jianqiang was introducing the company's development to the guestsMs. Carmen Montano, city councillor of Milpitas, poses for a photo with Mr. Wang jianqiang Boai NKY received high praises from delegates for our green development concept, clenn energy actions & energy conservation and environmental protection efforts. By fully understanding of Boai NKY's business distribution in precision medicine market, our visitors begin to place great hopes to the application prospect of Boai NKY's new medical detection technologies apply to clinical medicine. Senator Ms. Carmen Montano from Milpitas city (where Bio Vision compnay located) was very suprised & excited about our acquisition of Bio Vision. This is the first time she visits China, but China's development is quite beyond her expectation. She's willing to do the best to motivate interactions between Chinese and US companies for healthy & rapid growth in business. Relevant leaders from Henan Provincial Government, Jiaozuo Municipal Government and Boai County Government participated in the conference.
Read more<<The annual product-promotion tour of Boai NKY Pharmaceuticals Ltd. was successfully held in Malaysia & Indonesia between March, 25th~28th, 2019.Conference photograph of Boai NKY staff, conference sponsor (Narda Tita) & customer representatives-took in Indonesia.Dr. Herbert Ulmer (fifth from right), chief scientist of Boai NKY. Mr. Wojciech Bobecki (fourth from right), deputy GM of Boai NKY-Germany branch. Mr. Wang long (third from right), GM assistant of Tianjin Boai NKY international ltd., and staffs from Narda Tita.The product-promotion tour is a clear sign which shows that Boai NKY is stepping into market of Southeast Asia. We are going to focus more on customer service & technical support. Expecting to futhering cooperation with our customers on technical communication & collaborative R&D.The product-promotion tour brought our customers a deep understanding on competence of Boai NKY & quality of our products. They are looking forward to connecting with our engineers for customized solutions.Dr Herbert Ulmer, chief scientist of Boai NKY.Mr. Wang longNot only can providing high quality pharmaceutical excipients, Boai NKY also be willing to technically support our customers on regulations, supply chains, environmental protection & prodcut formula. A full set of pharmaceutical-excipients solution is what we are committed to offer.
Read more<<